thigrlsrk
- Roche gets approval in Japan for Elvidys( Sarepta s GT for DMD) 3-8 yrs.
- The fucker can't mandate egg prices how's he going to do it with drugs. His kids are short pharma today you can bet on that.
- Reposted by thigrlsrkTrump’s new Qatar Force One is getting some criticism.
- Reposted by thigrlsrkEvery day I will marvel at how hard James Comer tried without success to prove that Biden was tangentially corrupt and how little of a shit he gives that Trump is demonstrably, outrageously corrupt.
- Sarepta current MC under 4 B, 2.5 to 3 B in revenues this year, 600 million in cash. 16 to 20 B would be a normal Valuation. Analysts say Key drug in trouble -it is not. Only viable choice, approved, life saving. There is NO New safety concern.
- JMO but if you aren't buying Sarepta tomorrow You are going to miss a very fast rip too 200. 2.5 B in projected revenues that will more then likely be beaten is not the revenue of a 6 B MC company.
- Reposted by thigrlsrkPage One in Philly: @inquirer.com
- Reposted by thigrlsrkYou forgot to mention she resigned in protest in January after you killed her cartoon about your plutocrat owner.
- The Pulitzer Prize for illustrated reporting and commentary goes to @anntelnaes.bsky.social, for various works that appeared in The Washington Post. This is her third Pulitzer recognition.
- Reposted by thigrlsrkThoughts on this? >> GlobalX, airline used for Trump deportations, gets hacked: report >> Comment below! #AI #IoT #industry40 #mhealth #healthtech
- Reposted by thigrlsrkHearing a lot of chatter about a possible ICE operation tomorrow and Wednesday in the DC area specifically targeting restaurants and delivery drivers.
- 🚨🚨🚨SUBWAY RESTAURANTS, DOOR DASHERS, AND OTHER EATERIES WILL BE TARGETED BY ICE ON TUESDAY AND WEDNESDAY IN WASHINGTON, D.C. migrantinsider.com/p/ice-raids-...
- Reposted by thigrlsrkRecommendation from @brianstelter.bsky.social. Check out a new report from "Bright Line Watch." These are survey results based on "threats to democracy and academic freedom." "Threats to democracy and academic freedom after Trump's second first 100 days" brightlinewatch.org/threats-to-d...
- Reposted by thigrlsrkShe’s always correct.
- Reposted by thigrlsrk[Not loaded yet]
- Reposted by thigrlsrk
- Reposted by thigrlsrkThis gets papered over as old man yelling at clouds but this is impeachable by itself. Greenland is our ally which has allowed a continual U.S. military presence since WWII, including a vital part of our missile defense and space surveillance. Threatening them is unacceptable.
- Phase 3?? Interesting! LGMD 2e and 2d are ahead of 2c so that means all 3 are effectively at P3. Moving fast as platform (sarcanopathy) approvals….. $srpt
- $RHHBY $SRPT Roche - expected filing dates for delandistrogene moxeparvovec (SRP-9001): 0 to <4 years old - 2027; ambulatory 8 to <18 years old & non ambulatory DMD - 2027. #Elevidys #GeneTherapy #Duchenne muscular dystrophy #RareDisease
- Reposted by thigrlsrk[Not loaded yet]
- Reposted by thigrlsrk[Not loaded yet]
- If u think there are doc or patients questioning Elevidys safety, and what are the issues you should watch this: www.youtube.com/watch?v=68SN...
- Reposted by thigrlsrk[Not loaded yet]
- Reposted by thigrlsrk[Not loaded yet]
- Reposted by thigrlsrk[Not loaded yet]
- With the amount of investment in Sarepta Roche already has , I can't believe they don't want all the revenues for every DMD drug(4) and the 4 LGMD drugs now in the clinic. They still have 1.7 B to pay. BO coming on EMA approval. JMO
- $SRPT officially updated to fully enrolled/not recruiting: "Study to Evaluate the Safety, Tolerability, and Efficacy of SRP-9004 Administered by Systemic Infusion in Limb Girdle Muscular Dystrophy Type 2D/R3 Participants in the United States (DISCOVERY)" clinicaltrials.gov/study/NCT067...
- "Strategic Uncertainty" Is the new "We fucked shit up good but don't want to admit it.
